Back to listing



2RT® in the Fundamental Research Program of the LEAD clinical trial

Professor Erica Fletcher, PhD, Leader of the Fundamental Research Program in the Laser for Early AMD (LEAD) clinical trial, explains how the 2RT® unique mechanism of action may remove the early signs of age-related macular degeneration. Professor Fletcher highlights the distinctive differences that set 2RT® apart from current conventional retinal lasers.

Welcome to Ellex Global. Continue to Ellex USA at ellex.comus/
Let's go!
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More